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Abstract
Background: We conducted a pilot study of an intervention to facilitate patients’ 
agenda setting in clinical consultations. The primary aim of the study was to test the 
feasibility of running the randomized controlled trial. A secondary objective was to 
assess the extent to which patient and public involvement (PPI) could contribute to 
the process of qualitative data analysis (QDA).
Aims: To describe a novel approach to including patient partners in QDA; to illustrate 
the kinds of contribution that patient partners made to QDA in this context; and to 
propose a characterization of a process by which patient involvement can contribute 
to knowledge production.
Methods: Six patient and public representatives were supported to contribute to 
data analysis via a range of modalities. During a series of QDA workshops, experi-
enced research staff role- played consultations and interviews, and provided vi-
gnettes. Workshop data and PPI diaries were analysed using thematic discourse 
analysis.
Results: We characterized a process of thesis, antithesis and synthesis. This PPI 
group contributed to the rigour and validity of the study findings by challenging their 
own and the researchers’ assumptions, and by testing the emerging hypotheses. By 
training PPI representatives to undertake qualitative data analysis, we transformed 
our understanding of doctor–patient consultations.
Conclusions: This research required changes to our usual research practices but was 
in keeping with the objective of establishing meaningful patient involvement for a 
future definitive trial. This work was informed by concepts of critical humility, and a 
process of knowledge production enabled via the construction of a knowledge space.
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1  | INTRODUC TION
Enabling patient and public involvement (PPI) in health services 
research is now a prerequisite.1-4 Two of us have theorized PPI as 
“knowledge spaces,” that is spaces where expert knowledge and 
forms of lay knowledge can interact with each other on an equal 
basis.5 In this paper, we trace out how the interaction between 
different forms of knowledge works in practice drawing on an ex-
ample of PPI in qualitative data analysis to illustrate our points. 
Our analysis of the process has led us to conceptualize this inter-
action as a dialectical one, operating between lay and academic 
perspectives.
Previous work has indicated that PPI has a role in qualitative 
data analysis (QDA). It can correct researchers’ misinterpretations 
and challenge the ways in which findings are reported,6,7 and add 
value to the products of research analysis.8 While qualitative meth-
ods to augment clinical trials are mainstream,9 the role of PPI is often 
overlooked.10,11 Where PPI representatives have been involved in 
QDA alongside clinical trials, the impact of such involvement is often 
unclear.12
Examples of PPI in QDA as explicit emancipatory practice, 
sometimes described as community- based participatory research 
(CBPR),13 are prevalent in sociological research and achieved by 
tailoring how data are presented, engaged with, managed and 
categorized. Working with disadvantaged women, Jackson14 pro-
vided facilitation alongside simplified instructions and processes, 
such as encouraging participants to summarize data in lay lan-
guage. Conducting analysis with people with learning disabilities, 
Nind15 recommended tailoring approaches to local contexts, with 
academics variously taking on the role of “trainer, coach, scaf-
folder, mentor, partner in dialogue, co- learner, reciprocal learner 
and practical facilitator.” Kaomea16 has also shown that indige-
nous participants work with a different set of perspectives and 
tools when undertaking analysis, which may challenge taken for 
granted research practices, allowing findings to be challenged and 
re- examined.
The underpinning philosophies of CBPR and PPI are commensu-
rate, with both valuing meaningful partnership and collaboration to 
achieve change in the conduct and products of research.17 We, aca-
demic co- authors JF, AG, and NB, also drew on the literature about 
critical humility and participatory research to guide our conduct.13,18 
Emancipatory practices can be fostered by researchers’ “critical hu-
mility,” or lifelong commitment to self- evaluation and critique, as life-
long learners and reflective practitioners.18 The political imperative 
is to subvert or challenge the status quo (here the canon of accepted 
research methods and practices), with the objective of enabling 
those who are traditionally the focus of studies (e.g. “patients”) to 
understand their world in order to transform it—a form of “catalytic 
validity”.19 Although Lather20 proposed that catalytic validity needs 
to be consciously designed into the research process in order to de-
mocratize knowledge, Baines21 contends that facilitating meaningful 
PPI contributions to knowledge would require a shift in the politi-
cal economy of universities and research funders. Furthermore, the 
selectivity with which PPI representatives are chosen (reifying some 
voices to the detriment of others) has also been questioned.22,23 
However, this situation is beginning to change.24,25
In this study, as the aim was to ensure that patients’ concerns 
were addressed in the consultation, a correspondingly emancipa-
tory approach to the data analysis required patients’ perspectives 
to inform the data analysis. Crucially, analytic judgements about 
whether the intervention had indeed facilitated the discussions 
of patients’ concerns should be informed by patient perspectives. 
Conventionally, these judgements have been made by academic re-
searchers alone.26
1.1 | Diabetes Intervention for Agenda Trial (DIAT)
We conducted a pilot study of a pre- consultation intervention in 
which patients were supported by health- care assistants (HCAs) to 
complete a Web- based intervention to facilitate the production of 
“their own agenda” for discussion in a consultation with their dia-
betologists (Diabetes Intervention for Agenda Trial (DIAT);27,28). By 
combining trial and qualitative methods, we sought to identify how 
the intervention influenced consultations, and decide whether pro-
ceeding to a full trial was appropriate.
Patients were involved at all stages, in order to increase the 
probability that the intervention would be adopted in practice.29 
The research question was generated from a prioritization exercise, 
undertaken by the National Institute for Health Research (NIHR) 
Collaboration for Leadership in Applied Health Research and Care 
in the South West Peninsula (PenCLAHRC) with active involvement 
from the Peninsula Patient and Public Involvement Group (PenPIG). 
People with diabetes (including PPI representative 1 or “PPI1”) sug-
gested that outpatient clinic appointments are pressured times, 
where health professionals can overlook issues that are worrying 
patients or where patients can feel inhibited from voicing their con-
cerns. Supported by a PPI Research Fellow (AG), two members of 
PenPIG (FH-G and JH) who have diabetes joined the research team 
as funding co- applicants and members of the project management 
team. They co- wrote the study documentation, assisted with train-
ing the HCAs to deliver the pre- consultation intervention, partici-
pated in the data analysis and disseminated preliminary findings. 
Eight additional people with diabetes, recruited from the NIHR 
Diabetes Research Network and Diabetes UK, provided feedback on 
an early iteration of the intervention, and another participated in the 
trial steering group. With 4 other members of PenPIG, the two co- 
applicants (“PPI2” and “PPI3”) participated in a PPI qualitative data 
analysis group (“PPI group” with R denoting Researcher).
Seventy- one patients were randomized to either the inter-
vention or usual care.26 With participants’ and diabetologists’ 
consent, we audio- recorded intervention sessions and clinical 
consultations, to explore how participants generated and uti-
lized the intervention. Thirteen patients randomized to receive 
the intervention consented to be recorded and twelve had both 
an intervention session and a consultation recorded, while one 
had only their consultation recorded. Twelve control patients 
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consented and had a “usual” consultation recorded. Recording 
consultations facilitated our understanding of the impact of 
the production of an agenda on the clinical consultation, and its 
subsequent use in practice when compared with usual care.24,30 
Author A conducted 12 semi- structured interviews with a conve-
nience sample of participating staff and 12 patients (6 in each trial 
arm) to explore wider organizational factors. Interview questions 
were based upon the existing literature and PPI perspectives 
and aimed to capture staff and patient experience of diabetes 
consultations and the intervention specifically. Data were tran-
scribed verbatim, anonymized and managed using Nvivo soft-
ware. Preliminary framework analysis31 facilitated deductive and 
inductive analysis, enabling the exploration of the role of the in-
tervention and trial processes alongside the elicitation of patient, 
provider and PPI perspectives.
Qualitative data analysis began with JF and a diabetes special-
ist nurse (DSN) co- applicant independently familiarizing themselves 
with the first 20 consultations.32 In the control arm, we explored the 
usual consultation style of each participating diabetologist. In the in-
tervention arm, we explored the extent to which diabetologist used 
the agenda form as a guide for the consultation. A preliminary chart-
ing exercise (Table 1) allowed us to identify relationships between 
the process of agenda identification and agenda use.23 Thus JF and 
the DSN co- applicant identified a preliminary typology of consul-
tations (patient ignored, diabetologist led, patient led, diabetologist 
and patient led).
The aims of this study were to describe a novel approach to 
involving patient partners in QDA; to illustrate the kinds of contri-
bution that patient partners made to QDA; and to propose a charac-
terization of a process by which patient involvement can contribute 
to knowledge production.
2  | METHODS
2.1 | Training
JF, AG, and NB trained a group of six PPI representatives (the PPI 
group, including co- applicants PPI2 and PPI3), in QDA techniques 
(such as paying attention to nuances in consultations, and con-
structing patterns within and across consultations32) during three 
workshops. During the workshops, the PPI group had access to 
verbatim transcripts of consultations and in- depth interviews, but 
data governance considerations meant that data access was con-
fined to the workshop. The PPI group did not listen to the audio- 
recordings of the transcripts directly, to maintain confidentiality. JF 
TABLE  1 Extract from preliminary charting exercise
Demographic data Intervention Agenda form Consultation 
Patient: XXXX 
Diabetologist: XX 
Allocation: 
Intervention
Facilitator: XX 
Age: XX 
Gender: X 
Date: xx.xx.xx
F provided information and support as 
per training. 
P struggles to read the screen. Needed 
text enlarged and moved chair closer. 
P volunteers that he has problems with 
spelling ‘I suffer from…I can’t spell, so’, 
and F spells out ‘blood sugar’… 
[long pause] 
P: “Last time, no, the time before, I saw 
[Consultant]. At the end of the 
consultation he said to me, erm, ‘you 
have 10 seconds is there anything else 
you would like to ask me’ which I 
thought was, you know, ha ha ha…
couldn’t believe it, I was so gob 
smacked… I just walked out you 
know…Well he seemed very arrogant 
to me… Can I make a comment on it 
here?” 
F reiterates that P can write what he 
wants, but he does not make this 
comment. 
Ps concerns would ‘take pages’ 
because he has ‘any number of them’ 
— he says that he is ‘not trying to be 
facetious’ and ‘asks ‘how long have I 
got?’ as his diabetes has such an 
impact: ‘Physically can’t do what I used 
to do… I can’t eat what I used to do I 
can’t drink…I can’t…It completely 
alters your way of life, you know.’
Particular concern: “my blood 
sugar levels are always high i 
find that emotions play a big 
part in raising these levels can I 
increase the dosage of 
exenatide” 
Concern about diabetes: “there 
are so many ways it alters your 
there are too many to mention” 
Concern about medication: “can 
i increase exenatide what good 
will it do how much should i 
increase the insulin dose by to 
lower the sugar levels” 
Concern about managing 
diabetes: “diet”
No initial discussion of agenda form. 
D begins by identifying P on his records 
and checking which medication P is 
taking. P is slightly confused, and D 
says: ‘I suppose one thing this illustrates 
is really useful if you can bring a copy of 
your prescription with you.’ 
P says that he recently had a heart 
attack, but D cannot find a record of 
relevant blood tests, and D asks P if he 
is ‘quite sure’ of when he was in 
hospital. 
D says that a recent HbA1c result 
‘wasn’t very good’ and P admits that he 
has been struggling with self- 
monitoring, and has been having high 
results, which he attributes to stress 
about his sisters illness. 
D then refers to the agenda form: “Okay 
now you have got this list of questions 
here for the study and the first thing 
you ask is my blood sugar levels are 
always high I find the emotions play a 
big part in raising these levels. Can I 
increase the dose of Exenatide? The 
answer to that last question is no, you 
can’t.” There is a lengthy discussion re: 
Exenatide, with D proposing other 
medications to control HbA1c, and P 
suggesting that D has not got his dose 
correct
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and AG therefore role- played the anonymized consultations from 
the charting exercise, making sure that they captured the audible 
nuances of the audiotape, and provided vignettes which summa-
rized the “cases.” Role- play provides insight into social interaction 
and can provide a stimulus for discussion.33 Vignettes are stories 
about individuals, situations and structures, which allow actions to 
be explored in context and provide a less personal means of explor-
ing sensitive topics.34
In Workshop 1 (3 hours), the researchers introduced the study 
to the PPI group members who were unfamiliar with the project 
and the aims of the workshops. They described data collection 
and preliminary analysis to date. Large data matrices were used 
to demonstrate how the researchers had conducted their prelim-
inary coding, and participants were given instructions as to how 
they might produce their own codes about “what is going on” and 
“whose agenda is dominant” from the data that they would be 
given. The researchers then provided the PPI group with a vignette 
(Patient 1—Figure 1) and asked them to read the transcript and ob-
serve a role- play of a consultation in the usual care arm of the trial. 
PPI participants were then provided with the researchers’ prelim-
inary typology, as a stimulus to develop their own codes. The re-
searchers had produced a form to guide participants in conducting 
their analysis, but this was felt by the group to be too constraining. 
Instead, “codes” were identified from line- by- line discussion of the 
transcript. These analytical discussions were captured by the re-
searchers using a flip chart. The skilled PPI facilitator summarized 
PPI discussions and probed further for clarification. Notes of these 
discussions informed revisions to the preliminary coding frame, 
which, in turn, were fed back to the PPI group and shaped their 
subsequent analysis.
In Workshop 2 (6 hours), role- play was used to portray a con-
sultation in the intervention arm of the trial (Patient 2—Figure 1) 
and a subsequent qualitative interview in which the participant 
discussed his experience, alongside a contextual vignette. The PPI 
group read and discussed transcripts from both the consultation 
and interview, and were asked to critique and develop the typol-
ogy. In Workshop 3 (2 hours), the PPI group was provided with their 
revised typology, with the codes that they had identified, sup-
ported with descriptors from the previous discussions. They were 
given 4 further vignettes from a purposive sample of the consul-
tation data. In small groups, participants led the analytical discus-
sions, testing the codes and descriptors against the data, in the 
same way that teams of qualitative researchers conduct analytical 
discussions.
Thus, over the course of three workshops, and using a hands- on 
approach, the researchers and the PPI group went through the key 
stages of framework analysis, consisting of familiarization with 
the data, coding, developing an analytical framework, applying the 
framework, charting and interpreting the data.31,33
2.2 | Data collection
The 2 PPI co- applicants (PPI2 and PPI3) kept diaries and included 
information which they felt comfortable sharing with the wider 
research team.35 Repeat semi- structured interviews (2 qualitative 
interviews, one in each year of the project, with each of the two co- 
applicants), conducted by the PPI facilitator (AG), elaborated upon 
the reflections captured in the diaries and changes in experience 
over time.36 PPI co- applicants were asked about their experience of 
participation, their identification of barriers and facilitators to par-
ticipation, and their perceptions of the value that their contribution 
made to the research. The QDA workshops were audio- recorded. 
Ethical approval for the original proposal and subsequent amend-
ments was granted by the NHS Research Ethics Committee North 
West—Preston (13/NW/0123). The 2 PPI co- applicants provided 
written consent for their diaries and interviews to be analysed. As 
the group’s PPI analysis was a PPI activity to shape research, NHS 
REC approval was not required.
F IGURE  1  Illustrative vignettes
Patient 1:
This 28-year-old woman was seen in outpatients at Hospital 1. She was 
randomized to the “usual-care” arm of the study and saw her diabetologist as 
usual. She has type 1 diabetes and was concerned about “hypos’ and panic 
attacks.  This consultation was 19 minutes. On the baseline questionnaire, she 
indicated that she did not have an eating plan. At 3 months post-consultation, she 
repeated that she did not have an eating plan and that she ate high-fat foods and 
chocolate. She stated that she had not received dietary advice in the previous 2 
years. At six months post-consultation, she indicated that she had still not 
changed her treatment.
Patient 2:
This 57-year-old man with type 2 diabetes was seen in outpatients in Hospital 2. 
He was randomized to the “treatment arm” of the study, so before his consultation 
he was seen by a health-care assistant, used the Web-based intervention and 
produced an agenda form. The consultation was 35 minutes.  He was the only 
study participant who did not give consent for his intervention session to be 
recorded, and he implied that this was because of his concern about sexual 
problems. However, he was the only person in the treatment arm, to have his 
consultation with the Diabetologist recorded and participate in an explanatory in-
depth interview. 
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2.3 | Data analysis
Thematic discourse analysis was developed over the course of 3 
workshops using all sources of data, paying attention to micro- level 
discourse and the construction of the meaning of involvement to il-
lustrate the cumulative process of knowledge production in a knowl-
edge space31,32 by Authors JF, AG, and NB, with further clarification 
from FH-G and JH. The results of each workshop are presented in 
turn, reflecting our analysis at both a workshop and cumulative level, 
and our objective of assessing the contribution of PPI to the process 
of QDA.
3  | RESULTS
3.1 | Workshop 1: Hypothesis testing
By providing the PPI group with a preliminary typology, the ac-
ademic co- authors were demonstrating an analytical process 
without suggesting that the PPI group should validate those sug-
gestions.37 In terms of the critical humility of the researchers, and 
recognizing that our preliminary analyses were led by our own as-
sumptions, we saw this as part of a conversation in which we were 
opening ourselves up to their experiential knowledge and interpre-
tations as one would with other research and clinical partners.38 
The PPI group subsequently developed the preliminary typology 
by proposing the terms “patient identified” (rather than “patient 
led”) and “diabetologist facilitated” (rather than “diabetologist led”) 
as more nuanced, with subsequent rich discussions forming coding 
descriptors. With regard to “patient ignored,” the PPI group were 
able to describe the challenge of voicing the patients’ agenda in 
usual care by referencing what was different in the intervention 
consultations:
PPI2: In the [example from usual care], I would have 
been on my own; I was well left, you know, I was not 
part of it at all. This [example from intervention arm] I 
think he was joining in, he was involved, he was led a 
bit, but he was saying ‘Yes’, so he was obviously led in 
the right direction.  (Extract 1)
Similarly, a “diabetologist facilitated” style was identified in both trial 
arms; such that a diabetologist’s particular practice could both pre- 
date and be enhanced by the use of an agenda form:
PPI4: In the control arm, having a consultant who 
typically has a facilitative style [without agenda 
form] e.g. [Patient from control arm] talks about 
erectile dysfunction comfortably with the same 
consultant that [Patient from intervention arm] 
does.  (Extract 2)
By comparing the interview data with the consultation data, 
the PPI group were able to discern aspects that the “patients 
identified” (e.g. wrote down on the agenda form without the need 
to vocalize sensitive matters), and which patients later discussed 
in an interview:
PPI5: Yeah, I think the consultant did quite a good 
job really, and I think he also handled talking about 
erectile dysfunction [item on agenda form which pa-
tient did not articulate] very sympathetically and very, 
you know¸ sort of a way that perhaps hopefully was 
comfortable with the patient, too, which is, you know, 
sometimes, I think things like that are handled very 
poorly.  (Extract 3)
Finally, the PPI group discussed what constituted a “patient identi-
fied and diabetologist facilitated” agenda:
PPI6: I think, yeah, the doctor brought his agenda into 
play but he interweaved it into the patient’s agenda. 
He fed in at the important places with his stuff. 
 (Extract 4)
These newly identified codes and descriptors were then used by 
the research team to further analyse the data and develop display ma-
trices for each category:
Diabetologist facilitated: Rather than seeing the 
consultations as ‘Diabetologist led’ (implicitly paternal-
istic), the PPI group recognised and described a con-
sultative style that was facilitative. This could occur in 
the usual care arm of the study, where an agenda form 
was not produced, but when a diabetologists skilfully 
elicited the patient’s concerns.
Patient identified (intervention arm): Rather than as-
suming that the agenda form in the intervention arm 
would empower the patient (implicitly beneficial), the 
PPI group explained that it was sufficient and appro-
priate for the patient to produce an agenda to convey 
their concerns, with the diabetologists subsequently 
leading the consultation.
These nuanced codes are in keeping with the findings of Cribb 
et al39 who suggest that broader conceptions of shared decision- 
making allow for open- ended and fully dialogic ways of relating. These 
new codes were then applied to the whole data set and complete ma-
trices discussed again with the PPI group.
3.2 | Workshop 2: Challenging
Here, we explore one of the coding discussions (“patient identified 
and diabetologist facilitated”), to demonstrate that the PPI group were 
able to develop a refined typology of the consultations which chal-
lenged the assumptions of the project team, as well as their own 
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views. The group were discussing how to code a particular consulta-
tion where a diabetologist used a patient’s agenda form to frame the 
consultation:
PPI4: I got it when [consultant] said about the two 
agendas merging, I got that bit. If I was the patient 
I would think I would be happy-ish to hear that, you 
know, at least we’re going the right way.
PPI3: Who cares about [consultant’s] agenda, I’m here 
with my agenda! I’ve just worked on, brought it in, I 
don’t really care what his agenda is [laughs] I want my 
issues dealt with, you know. I mean, if somebody said 
that to me: well, whoopee do for you! Have I got what 
I want?   (Extract 5)
PPI3 was emphatic that “her agenda” should always be prioritized 
over that of the diabetologist. The discussion continued, as to when 
it would be appropriate for a diabetologist to question the patient’s 
agenda:
PPI3: I did wonder why the [consultant] didn’t probe 
more into why the patient didn’t want four injections 
a day…
R: You could also interpret that positively…if the pa-
tient has stated a preference they would like it to be 
that way, it’s not up to me to question that, it’s up to 
me to discuss whether we can actually…
PPI3: I don’t think I agree with that at all…there’s such 
an issue here about, you know, blood sugar control is 
so important for all the other things including cardio-
vascular disease.  (Extract 6)
Despite wanting her agenda to be enacted, PPI3 thought it re-
miss of the diabetologist not to challenge the patient’s underlying 
assumptions:
PPI3: I think if you’re going to be a good physician, 
then you have to recognise when you need to step in 
regardless of the patient’s agenda and I think it’s very 
good that he acknowledges the patient’s agenda and 
he’s following the patient’s agenda but on this point 
I think that he needs to explore it more with a view 
to giving this man the best possible treatment he can 
have… But definitely I think, you know, that may be 
on his agenda, but sometimes I think that they — the 
consultant should be overriding it with as much nego-
tiation as is possible.
R: So you said if I go I don’t care about the consul-
tant’s agenda, it’s my agenda.
PPI3: Yes.
R: What you’ve just been saying, actually, the consul-
tant should override the patient’s agenda if…
PPI3: Only in that situation…I don’t think, I can’t think 
of another scenario.  (Extract 7)
In this way, the group collectively challenged each other about 
assumed rules for consultation participation and caveats for the 
use of an agenda, and were able to move from a typology of pa-
tients and professionals, to scenarios when a patient’s agenda 
may or may not be appropriate.39 This particular thread devel-
oped into a discussion of whether a diabetologist should priori-
tize health concerns over a patient’s desire for quality of life, and 
PPI2 shared his experience of multimorbidity and polypharmacy:
PPI2: I balance it — I really want a better quality of 
life. At the moment I’m not getting it and my main 
thing is… it’s like the morning medication: fifteen 
tablets that I take and I can’t eat anything for at least 
an hour and a half because I feel sick, you know, and 
that’s not a good quality of life.
R: So would you want more- a kind of explicit discus-
sion about the quality of life that maybe if you took 
fewer medicines or if it was changed whether that 
might bring increased risks, you know, because in a 
way, that would be up to you. What kind of a balance 
would you want between quality of life and risks of 
things getting worse?
PPI2: I think, yeah, I would like that sort of discussion, 
yeah…  (Extract 8)
The group members questioned PPI2 about his medication and he 
conceded that he valued his consultant being directive:
PPI2: My consultant… said to me…if we don’t do 
something you won’t be here in twelve months, you 
know, so it was drastic for me…. The drugs I’m on, and 
I’ve been on them so long, it’s, you know, the dam-
age is already done, you know. I may probably have 
a limited amount of life left but I know what I can do 
and how long, do you know what I mean? I know my 
limitations. I don’t think this guy knows his limitations. 
 (Extract 9)
After PPI2 was so open about his own experience, PPI3 revised her 
own position again:
PPI2: Actually I’m just going to confound all of my 
arguments…With PPI3 talking I’ve just remembered 
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something about quality of life over health care, and 
at one point my consultant and I agreed that if I had 
any more insulin I would put on more weight, I would 
develop more insulin resistance and blood sugars 
would go up and go up. So we actually agreed, despite 
the fact that my HbA1c was quite high, that having 
more insulin at that point was just going to make all of 
my problems worse. But then, looking at it back down 
the line, that’s probably why I’ve got retinopathy, you 
know. I’ve lost a lot of my sight on the periphery, can’t 
drive at night…  (Extract 10)
This account demonstrates the importance of trust and continuity 
between patients and providers and the importance of continuity of 
care; but also the importance of trust and continuity within the PPI 
group, such that difficult conversations could be surfaced, tensions ex-
plored, and misunderstandings or assumptions resolved. The contrast-
ing and complementing views of the PPI group acted as a brake on any 
assumption that the researchers might have made about the patient’s 
agenda always having primacy, and the quality of their argument aug-
mented knowledge about the contexts in which an agenda form may 
or may not be useful.
3.3 | Workshop 3: Re- challenge
In the final workshop, members of the PPI group demonstrated their 
ability to analyse and synthesize the findings from the qualitative 
data. This illustration depicts the confidence with which they could 
apply their understanding (or analytical framework) to vignettes pro-
duced from additional consultations and interviews:
PPI6: Well we’ve got a 42 year old diabetic Type 1 
who would appear to have been visiting a diabetic 
consultant and wasn’t very excited about being there, 
answered all the questions negatively, didn’t commit 
anything that he wanted to improve and out of no-
where the consultant said about changing the insulin 
regime but didn’t quantify it, and then he said ‘Oh, 
I’ll quite happily do that because of me brother.’ So 
there’s a note in there which he never picked up on 
‘Why, what’s wrong with your brother?’ and he’d just 
died, he was a diabetic and he’d died of some cardiac 
problem. Er, and at the end of it, you know, it was 
just another meeting he’s been to out of his 84 over 
42 years that didn’t go anywhere. And, you know, he’s 
going through the motions for them… Yes, it’s con-
sultant led, you can identify that from the script here 
to point to consultant led, yes, there are still, um, the 
agenda unvoiced, yes, there’s a limit in there.   
     (Extract 11)
Members of the PPI group were given a further opportunity to 
amend the analytical typology, and it was concluded that the data 
fitted the categories earlier identified by the PPI representatives. 
Finally, the group were able to produce a highly nuanced synthetic ac-
count of best practice (and new knowledge):
R: What’s good practice here?
PPI4: I think it should depend on the patient and, 
to me, it should be - appear in different [analytical] 
boxes with different patients, ‘cause everybody’s not 
the same. And everybody won’t be able to initiating 
it, you know, some might just be going in and waiting 
for the doctor to actually start it off and ask them the 
questions like we did with one of them.
PPI2: And based purely on that individual, an individ-
ual patient.
PPI3: I suppose in an ideal world, with the same con-
sultant, different patients; you would hope to see the 
columns populated differently.  (Extract 13)
In this final example, the PPI group identified that diabetes consul-
tations required care that was tailored to the needs of the patient and 
contextual, suggesting that an agenda form was helpful in some situa-
tions but not others—a potential challenge to the premise of the feasi-
bility study. Thus, the PPI contribution and wider analysis of the DIAT 
feasibility study suggested that the study protocol would need further 
development before a definitive randomized controlled trial would be 
warranted. By equipping the PPI group with analytical techniques, they 
were able to engage with the data and crucially, in this clinical trial of a 
patient- centred intervention, make the findings clinically relevant.
4  | DISCUSSION
There have been calls both to standardize the practice of involving 
participants in clinical trials40 and the reporting of involvement in 
qualitative analyses.41 We have responded by demonstrating the 
process which was undertaken by the PPI group, facilitated by ex-
perienced qualitative researchers (JF and NB) and skilled PPI fa-
cilitation (AG). By applying our in- depth knowledge of qualitative 
research theory and PPI practices, we were able to improve the 
inclusivity and understanding of this PPI group,42 by developing an 
approach more akin to the emancipatory and participatory practices 
described in the sociological literature.14-16
To facilitate catalytic validity, defined as the degree to which re-
search moves those it studies to enable them to better understand 
the world and transform it,19 the academic researchers reflected on 
their own practices and attempted to foster mutually beneficial and 
non- paternalistic partnerships with members of the PPI group.18 
This required the deconstruction of established qualitative prac-
tices, to enable the PPI representatives to participate in the inter-
pretation of data and knowledge production. This experience led us 
1118  |     FROST eT al.
to reflect that the emancipatory or ethical imperative of PPI is not at 
odds with the scientific methods employed in clinical trials (of testing 
and refining hypotheses).
In trying to understand and conceptualize the process de-
scribed above, both for ourselves and others, we came to the con-
clusion that what had taken place could be best understood as a 
dialectical interaction made possible by the creation of a knowl-
edge space where people with differing social relationships to the 
research process,.that is patients and academics could, neverthe-
less, interact. In health care, professionals are in possession of a 
particular form of cultural capital (accumulated knowledge, skills 
and behaviours) based on their qualifications, and similar privilege 
applies for health services researchers in the arena of research.5 
Previous research has identified how non- research–based profes-
sionals can feel isolated by the process of having specific tasks 
within a trial, which can inhibit their sense of agency.43 Clinicians 
have suggested that lack of time allowed by planned research ac-
tivities has limited their ability to adequately recruit patients to 
clinical trial targets,44,45 while others have detailed the emotional 
labour of managing patients’ (mis)understanding of randomiza-
tion processes.46 Even though the PPI activities in this study were 
crafted to achieve longitudinal inclusion, this did not mitigate the 
partial view of the research that PPI collaborators expressed early 
in the research process. We thus considered the experience as 
akin to the boundaries of inclusion described by some clinicians 
participating in trials. However, by making changes to our usual 
research practices, the contribution to QDA specifically was per-
ceived by PPI collaborators was a particularly valuable experience, 
because it went some way towards valuing their knowledge and re-
distributing power, which enabled them as “knowledgeable actors” 
within a knowledge space.5 In turn, this enabled us to develop a 
far more nuanced understanding of diabetology consultations and 
identify the limitations of our intervention within current health- 
care provision.27,28
In 1808, Fichte47 identified that forming a thesis involves set-
ting out or laying down an argument. The thesis is then challenged 
by its antithesis. This challenge is then itself challenged, and a pro-
cess of reconciliation is sought in a synthesis where both views are 
accommodated or surpassed. In an ongoing process, this synthe-
sis becomes the starting point for a new cycle of knowledge cre-
ation.48 For Fichte, this process was not the preserve of academics, 
but rather antithesis was the process by which others held the elite 
in check.49 In 1940, Popper50 contended that this dialectic triad (of 
thesis, antithesis and synthesis) surpassed the traditional scientific 
method of trial and error, as it contained an imperative to reconcile 
or further explore different perspectives, which were absent from 
other methods of scientific enquiry.
A thesis is formed when an idea or hypothesis is outlined, and 
we began our analytical process by orientating the PPI group to our 
preliminary typology in response to the overall research question 
which the pilot trial sought to answer. The PPI group subsequently 
developed the preliminary typology by proposing their own terms. 
An antithesis is the challenge to a thesis by the presentation of 
contrasting or opposing views, and as the PPI group discussed the 
data with each other, they began to challenge the researchers’, 
each other’s, and indeed their own interpretations. With such a 
wealth of experience, we did not expect the PPI group to have a 
unified voice, and here, we demonstrate how they wove individual 
stories into storylines which, as qualitative researchers, we typi-
cally think of as “themes.” A synthesis occurs when the challenge 
produced by an antithesis is itself challenged. It becomes the next 
thesis to inform the analytical process, which the PPI group en-
gaged with by testing out their own hypotheses. In the final anal-
ysis workshop, members of the group demonstrated their ability 
to analyse and synthesize the findings from the qualitative data. 
This approach may have utility in other areas of health services 
research, and clinical trials more specifically, for example when 
assumptions about the acceptability or effectiveness of trial inter-
ventions warrants further exploration to identify core components 
and their optimal alignment.29
By detailing our approach, we are able to suggest a template for 
how other researchers might facilitate PPI in QDA (Table 2). We are 
aware that this is one illustrative example of a broader dialectical 
process. Here, the PPI group was provided with a typology to initiate 
the dialectical process, although this initial “thesis” could have been 
generated by patients, with academics providing the “antithesis.” 
Similarly, the dialectic process could have continued, but we were 
constrained by the timeframe of the funded project.
A strength of this approach is that it facilitates meaningful 
patient and public involvement which we feel both augments the 
validity of the research findings and provides a replicable process 
that could be employed in other clinical trials or qualitative stud-
ies. A limitation might concern the individuals who were engaged 
in this study. Two members of the research team had diabetes, 
but we supplemented this involvement with workshops involving 
a broader group of people. This enabled us to surface tensions 
between perspectives of different PPI representatives, enabling 
us to develop a more nuanced understanding of the issues raise 
which contributed to a shared understanding of the research find-
ings. A further limitation might be the skill and training required 
by the research team to facilitate PPI in this way,51,52 which may 
be perceived as burdensome. This requires an understanding of 
the principles, practices and possibilities afforded by the various 
qualitative methodologies, as well as openness to the challenges 
of translating the theory and practice of research in order to make 
it accessible and participatory,53,54 rather than as a quick- fix or 
tickbox approach.
5  | CONCLUSION
We successfully trained and collaborated with PPI representatives 
to undertake qualitative data analysis which transformed our un-
derstanding of doctor–patient consultations,24 and the appropriate 
uses of an agenda form. This required changes to our usual re-
search practices, in terms of purposively constructing a knowledge 
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space to break down lay and professional boundaries; but was in 
keeping with the objective of establishing meaningful patient in-
volvement for a definitive trial. We propose that our knowledge 
production process of thesis, antithesis and synthesis can be used 
as a template for other researchers who work on clinical trials or 
health services research more generally. Furthermore, we suggest 
that researchers should document and analyse the nature of the 
interpretation itself.
We contend that the driver for actively involving patients and 
members of the public in clinical trials should not merely be its re-
quirement for successful funding.38 Rather, the imperative should 
be to develop more holistic understandings of complex problems 
via a change in the way that knowledge is produced,48 Dingwall 
et al47 proposed that qualitative research can augment the find-
ings of clinical trials and address the humanitarian issues of equity 
and effectiveness. We propose that by undertaking QDA with PPI 
representatives using a dialectic process, we collectively produced 
more valid and clinically relevant findings.
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TABLE  2 Template for PPI involvement in QDA
Objectives Activities
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For PPI representatives to make a contribution to 
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To improve researcher understanding Facilitate PPI input into: (as appropriate)
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participants, lay summaries.
• Intervention development
• Staff training.
• Qualitative topic guide.
To provide stimulus for analytical discussions Provisional coding frame produced by research team members
For PPI to make a contribution to QDA
For QDA to be accessible
To capture PPI perspectives 
Workshop 1: 
Training 
Role- play of consultations/interviews 
Provision of vignettes 
Data collection techniques: audio- recording, note- taking, flipchart, emails
Revision of coding frame as data collection and data 
analysis develop 
Revision of coding frame by researcher, (revision of topic guide/research practices 
could also be revised here)
For PPI to make a contribution to QDA
For QDA to be accessible
To capture PPI perspectives
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Revision of coding frame as data collection and data 
analysis develop
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Finalization of coding frame once all data have been 
accounted for
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To learn from the experiences of PPI collaborators 
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Repeat interviews and revisit diaries 
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To include PPI representatives in the dissemination of 
the research findings
PPI co- authorship on draft papers:
PPI input into paper writing and wider dissemination activities
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